Mehow Innovative Ltd
SZSE:301363
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| CN |
M
|
Mehow Innovative Ltd
SZSE:301363
|
18.8B CNY |
Loading...
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
200.9B USD |
Loading...
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
178.7B USD |
Loading...
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
146.6B USD |
Loading...
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
123.3B USD |
Loading...
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
110.5B USD |
Loading...
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
47.7B EUR |
Loading...
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
52.2B USD |
Loading...
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
50.3B USD |
Loading...
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
49.3B USD |
Loading...
|
|
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
38.2B USD |
Loading...
|
Market Distribution
| Min | -2 148% |
| 30th Percentile | 14.3% |
| Median | 23% |
| 70th Percentile | 34.6% |
| Max | 775.2% |
Other Profitability Ratios
Mehow Innovative Ltd
Glance View
Nestled in the nexus of China's thriving manufacturing sector, Mehow Innovative Ltd. emerged as a beacon of ingenuity in medical device manufacturing. Founded in 2005, the company has harnessed its expertise in precision engineering and cutting-edge technology to create an array of medical devices that improve patient care across global markets. Specializing in research, development, and production, Mehow Innovative has established itself as a pivotal player, fusing sophisticated technology with practical application. Its manufacturing prowess, centered in Shenzhen, benefits from China's robust supply chains and skilled workforce, enabling the company to produce cost-effective and high-quality medical solutions. Revenue for Mehow Innovative Ltd. flows from its strategic focus on the ODM (Original Design Manufacturer) and OEM (Original Equipment Manufacturer) segments, serving an array of clients who rely on the company’s ability to deliver tailored solutions. By partnering with leading healthcare firms, Mehow ensures a steady stream of business, offering customized product development that spans diagnostic, therapeutic, and monitoring devices. Furthermore, its commitment to stringent quality standards and compliance with international certifications fortifies its position in the competitive landscape, ensuring the trust and loyalty of a wide client base. Through innovation and reliability, Mehow not only survives but thrives in the ever-evolving arena of medical device manufacturing, leaving its mark on healthcare systems worldwide.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for Mehow Innovative Ltd is 39.2%, which is below its 3-year median of 40.6%.
Over the last 3 years, Mehow Innovative Ltd’s Gross Margin has decreased from 42.4% to 39.2%. During this period, it reached a low of 38.5% on Jun 30, 2024 and a high of 43.5% on Jun 30, 2023.